Streetbeat News

Regulatory

BMY

Bristol Myers Squibb has received a positive opinion from the CHMP for its drugs Opdivo and Yervoy as a first-line treatment for certain types of metastatic colorectal cancer. This development could enhance the company's oncology portfolio and market position.

Portfolio Pulse from

November 15, 2024 | 1:45 pm

DEC

Diversified Energy Company PLC reported strong Q3 performance with high production levels and expansion into environmentally beneficial initiatives. CEO Rusty Hutson Jr. discussed methane capture projects and potential regulatory impacts from the incoming U.S. administration.

Portfolio Pulse from

November 15, 2024 | 1:45 pm

IDRSF

Idorsia's TRYVIO, a once-daily dual endothelin receptor antagonist, is now available in the U.S. for treating difficult-to-control hypertension. It is designed to be used alongside other antihypertensive drugs for patients not adequately controlled on existing medications.

Portfolio Pulse from

November 15, 2024 | 1:15 pm

AAON

AAON, Inc. is reaffirming its commitment to the U.S. Department of Energy's Better Buildings Commercial Building Heat Pump Technology Challenge, leveraging strategic partnerships to tackle the challenge with confidence.

Portfolio Pulse from

November 15, 2024 | 1:15 pm

ETNB

89bio presented new analyses at The Liver Meeting® 2024, highlighting the potential benefits of pegozafermin in treating MASH patients. The analyses suggest pegozafermin's anti-fibrotic effects and the utility of non-invasive tests correlating with histological endpoints.

Portfolio Pulse from

November 15, 2024 | 1:15 pm

SMCI

Super Micro Computer Inc. (SMCI) is facing a delisting deadline, which has caused its stock to rise as investors anticipate the company's next move. The situation presents a critical moment for the server maker.

Portfolio Pulse from

November 15, 2024 | 1:15 pm

TDY

Teledyne Controls, a subsidiary of Teledyne Technologies, has announced the certification of its new onboard enhanced Airborne Data Loader (eADL XS™) for the Boeing 737NG aircraft series. Certification for other aircraft platforms is underway.

Portfolio Pulse from

November 15, 2024 | 1:15 pm

IFRX

InflaRx N.V. (Nasdaq: IFRX) has received a positive opinion from the CHMP of the EMA for its drug GOHIBIC (vilobelimab) for treating SARS-CoV-2-induced ARDS. The European Commission is expected to issue a marketing authorization soon.

Portfolio Pulse from

November 15, 2024 | 1:00 pm

TMSNY

Levi & Korsinsky has started an investigation into Temenos AG for potential violations of federal securities laws, following a report by Hindenburg Research alleging accounting irregularities and failed products.

Portfolio Pulse from

November 15, 2024 | 12:45 pm

COUR

Levi & Korsinsky has initiated an investigation into Coursera, Inc. for potential violations of federal securities laws following a revenue miss and lowered guidance in 1Q 2024.

Portfolio Pulse from

November 15, 2024 | 12:45 pm